Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Thomas

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Infection and Immunity|April 23, 2004
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1Armead H Johnson, Rose G F Leke, Nancy R Mendell, et al.
Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for PsychopharmacologyAlistair Burns, John O'Brien, , et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2012
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialRenee Romeo, Martin Knapp, Jennifer Hellier, et al.
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.
Plos One|December 19, 2008
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02Meta Roestenberg, Ed Remarque, Erik de Jonge, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort studyJoshua Harvey, Jennifer Imm, Morteza Kouhsar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2020
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and managementJohn O'Brien, John Paul Taylor, Clive Ballard, et al.
Malaria Journal|September 1, 2016
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in BandiagaraMahamadou A Thera, Drissa Coulibaly, Abdoulaye K Kone, et al.
Ebiomedicine|May 30, 2025
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorderStephen Joza, Aline Delva, Christina Tremblay, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Infection and Immunity|April 23, 2004
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1Armead H Johnson, Rose G F Leke, Nancy R Mendell, et al.
Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for PsychopharmacologyAlistair Burns, John O'Brien, , et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2012
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialRenee Romeo, Martin Knapp, Jennifer Hellier, et al.
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.
Plos One|December 19, 2008
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02Meta Roestenberg, Ed Remarque, Erik de Jonge, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort studyJoshua Harvey, Jennifer Imm, Morteza Kouhsar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2020
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and managementJohn O'Brien, John Paul Taylor, Clive Ballard, et al.
Malaria Journal|September 1, 2016
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in BandiagaraMahamadou A Thera, Drissa Coulibaly, Abdoulaye K Kone, et al.
Ebiomedicine|May 30, 2025
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorderStephen Joza, Aline Delva, Christina Tremblay, et al.
Pageof 11